MoneyWorks4Me

USFDA completes inspection at Ajanta Pharma’s Dahej formulation facility

26 Jun 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Ajanta Pharma’s Dahej formulation facility. At the end of inspection, USFDA issued no Form 483 to the said facility. The formulation facility at Dahej was inspected by US FDA from June 19, 2023 to June 23, 2023.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..